Posts Tagged ‘Berkely HeartLab’



Putting the Cart Before the Horse when Leading a Test to Market

April 28th, 2011
Posted by

Berkeley HeartLab’s experience with its KIF6 StatinCheckTM highlights the discrepancies between how well a test is marketed versus its clinical utility.
 
In 2008, the assay KIF6 StatinCheck genotype test was introduced as a laboratory developed test.  More than 250,000 tests, with a price tag of about $100 each, have now been performed. In December of 2010, Celera (Berkeley HeartLab’s parent company) submitted a pre-market approval application to the U.S. Food & Drug Administration (FDA) based on several studies. These studies suggested a relationship between carriers of the KIF6 gene and an increased risk of coronary heart disease (CHD) and statin response.
 
TheBerkeleyHeartLab states the test’s clinical value on its website as follows:
  Read the rest of this entry »

Tags: , , , , , , , ,
Posted in Our Views | 2 Comments »